Article
HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.
AIDS research and human retroviruses - 1 Jun 2013
Nicholaou Matthew J, Martinson Jeremy J, Abraham Alison G, Brown Todd T, Hussain Shehnaz K, Wolinsky Steven M, Kingsley Lawrence A
Abstract excerpt
Highly active antiretroviral therapy (HAART) has been successful in delaying the progression to AIDS in HIV-1-infected individuals. Exposure to HAART can result in metabolic side effects, such as dyslipidemia, in a subset of recipients. Longitudinal data and frozen peripheral blood mononuclear cell pellets were obtained from 1,945 men enrolled in the Multicenter AIDS Cohort. Individuals were genotyped for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
